# US 2026/0083496 A1 · Application of stimulation to enable circumferential ablation during rf ablation for rdn

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083496 A1
- Document ID: US20260083496A1
- Status: Published application
- Kind: A1
- Application number: 19/112,193
- Filed: 2023-09-07
- Published: 2026-03-26
- Earliest claimed: 2022-09-14
- Assignees: Medtronic Ireland Manufacturing Unlimited Company
- Applicants: Medtronic Ireland Manufacturing Unlimited Company
- Inventors: Gerry O. McCaffrey
- Web page: https://patentgrep.com/patent/US20260083496A1

## CPC

- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 18/0218: {with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip}
- A61B 18/1206: {Generators therefor}
- A61B 18/14: Probes or electrodes therefor
- A61B 2018/0022: {Balloons}
- A61B 2018/00434: {Neural system}
- A61B 2018/00577: {Ablation}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00702: {Power or energy}
- A61B 2018/0072: {Current}
- A61B 2018/0075: {Phase}
- A61B 2018/00994: {combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/0293: {using an instrument interstitially inserted into the body, e.g. needle}
- A61B 2018/1253: {monopolar}
- A61B 2018/126: {bipolar}
- A61B 2018/1417: {Ball}
- A61B 2018/1435: {Spiral}
- A61B 2018/144: {Wire}
- A61B 2018/1467: {using more than two electrodes on a single probe}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and method for performing a therapeutic procedure including navigating a therapeutic device to target tissue, applying a first stimulus to the target tissue via a stimulus delivery element to contract the target tissue about the therapeutic device, and applying a first therapy to the target tissue contracted about the therapeutic device to denervate the target tissue.

## Claims

### Claim 1

A system for denervation of target tissue comprising:
an elongate catheter;
a therapy delivery element operably associated with the elongate catheter;
a stimulus delivery element operably associated with the elongate catheter;
a stimulation source in communication with the stimulus delivery element, wherein application of a stimulus via the stimulus delivery element causes target tissue to contract on the elongate catheter to center the elongate catheter in the target tissue; and
a therapy source in communication with the therapy delivery element, wherein application of the therapy denervates nerve tissue of the target tissue.

### Claim 2 (depends on 1)

The system for denervation according to claim 1, further comprising two stimulus delivery elements formed on the elongate catheter.

### Claim 3 (depends on 1, 2)

The system for denervation according to claim 1 or 2, further comprising a second stimulus delivery element formed on a guide catheter.

### Claim 4 (depends on 1, 2, 3)

The system for denervation according to any one of claims 1 to 3, wherein the stimulus delivery element is formed on a guide wire.

### Claim 5 (depends on 1, 2, 3, 4)

The system for denervation according to any one of claims 1 to 4, wherein the therapy source and the stimulation source are a single electrical generator.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The system for denervation according to any one of claims 1 to 5, wherein a therapy source modality is selected from the group consisting of monopolar or bipolar radio frequency (RF), microwave, ultrasound, chemical, cryogenic, and combination thereof.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The system for denervation according to any one of claims 1 to 6, wherein a stimulation source modality is selected from the group consisting of bipolar or monopolar alternating current (AC), a direct current (DC), pulsed AC or DC pulses, biphasic pulses, multiphasic pulses, chemical, and combinations thereof.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The system for denervation according to any one of claims 1 to 7, further comprising a shape memory portion configured to alter a shape of the elongate catheter to a helical configuration such that the therapy delivery element is in contact with the target tissue.

### Claim 9 (depends on 8)

The system for denervation according to claim 8, wherein the therapy element is composed of one or more monopolar RF electrodes formed on the elongate catheter such that alteration of the shape contacts the electrodes on the target tissue in spaced relation to each other.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The system for denervation according to any one of claims 1 to 9, further comprising a balloon, wherein inflation of the balloon secures the elongate catheter relative to the target tissue.

### Claim 11 (depends on 10)

The system for denervation according to claim 10, wherein the therapy delivery element is a plurality of RF electrodes formed on the balloon.

### Claim 12 (depends on 10)

The system for denervation according to claim 10, wherein the therapy delivery element is a microwave antenna within the balloon.

### Claim 13 (depends on 10, 12)

The system for denervation according to claim 10 or 12, wherein the therapy delivery element is a plurality of ultrasound transducers formed on the balloon.

### Claim 14 (depends on 10, 12)

The system for denervation according to claim 10 or 12, wherein the therapy delivery element is one or more needles for injection of a chemical or cryoablation medium to the target tissue.

### Claim 15 (depends on 10, 11, 12, 13, 14)

The system for denervation according to any one of claims 10 to 14, further comprising a computer including a memory storing thereon an application that when executed by a processor:
causes the stimulation element to apply a stimulus proximate the target tissue to contract muscle fibers of the target tissue;
causes the therapy element to apply therapy to the target tissue; and
ceases application of the therapy to cease upon determination that the target tissue has been successfully denervated.
